Bengaluru, Apr 2: G S Krishnan, formerly regional President & MD, Novozymes South Asia Pvt Ltd, a Danish biotech company, has taken charge as the new President of India’s leading biotechnology industry organisation, the Association of Biotechnology-Led Enterprises (ABLE).
Kiran Mazumdar-Shaw, the Executive Chairperson of Biocon Limited, will continue as the association’s honorary non-executive chairperson, an ABLE statement said.
Krishnan will head a nine-member executive council that was elected last January for a three-year term starting on April 1, 2021.
The other office-bearers are Anand Anandkumar of Bugworks Research as Vice President & Treasurer, and Ravi Bhola of K&S Partners will be the new General Secretary of ABLE.
Aiming to further catalyse the growth of India’s USD 70 billion BioEconomy, the Association has also set up an ABLE Business Council, that will be chaired by former ABLE President and founder of biotech startup Jananom,P M Murali.
This Council will comprise all the past presidents of ABLE such asKiran Mazumdar-Shaw, K K Narayanan, Vijay Chandru and Shrikumar Suryanarayan.
“India’s BioPharmaceutical segment has played a commendable role in the discovery and manufacturing of COVID- 19 vaccine during the pandemic and we need to build on this great momentum and lead the world in playing a critical role, identifying our capabilities,” saidKrishnanwhile taking over as the new ABLE President for 2021-24.
Krishnan added that opportunities in the BioIndustrial and BioAgriculture are also highly promising and require a conducive regulatory framework.
The 4,300-plus Biotech startups too will contribute significantly for the growth of the biotech industry and requires all the support to grab near-to-market opportunities, he said.
“It will be my endeavour to focus on these opportunities working together with the ABLE team and all the relevant stakeholders in making India a USD 150 billion Bio- based Economy by the year 2025,” the ABLE President said.
The outgoing ABLE president and chairman of Sea6Energy,Shrikumar Suryanarayannoted: “Our biotech industry demonstrated its power to heal the world during the ongoing COVID-19 pandemic by providing super quickdiagnostic solutionsand compressing thedevelopment time to roll out vaccines againstthe SARS CoV-2 virus within a year…”
The other elected members of the ABLE Executive Council (2021-24) are: Kavitha Iyer Rodrigues (Zumutor Biologics), Ezhil Subbian (StringBio), Shama Bhat (Bhat Biotech), Shriram Ragavan (Jananom) and Venkat K Bundla (Garphi Biosciences).
Founded in 2003, ABLE represents more than 400 companies in the country’s biotech ecosystem, the statement added.PTI RS SS
(PTI)

Follow our WhatsApp channel